血清25(OH)D在妊娠期高血压疾病孕妇中的水平及与其严重程度的关系
Serum 25(OH)D Levels in Pregnant Women with Gestational Hypertension and Its Relationship to Its Severity
DOI: 10.12677/ACM.2022.1281116, PDF,   
作者: 刘淑媚：内蒙古医科大学，内蒙古 呼和浩特；杨晓彦：内蒙古自治区妇幼保健院，内蒙古 呼和浩特
关键词: 妊娠期高血压疾病；25(OH)D相关性；Hypertensive Disorders of Pregnancy； 25(OH)D Relevance
摘要: 妊娠期高血压疾病(hypertensive disorders of pregnancy, HDP)是孕妇在妊娠期间所患有的一种特有的高血压疾病，其也是严重危害孕妇和胎儿的健康发育的重要因素，同时，在当前情况下也是导致孕产妇发生死亡的重要原因之一。有研究表明25(OH)D是妊娠期高血压的独立风险因素，但其机制复杂，临床相关学说尚不明确，还有待进一步研究。目前大量研究表明25(OH)D与妊娠期高血压疾病存在相关性，其缺乏可能会导致妊娠期高血压疾病发生概率大幅度提升，在妊娠期高血压疾病的发生发展中发挥不可或缺的作用。
Abstract: Hypertensive disorders of pregnancy (HDP) is a specific type of hypertensive disorder that occurs during pregnancy and is a serious risk factor for the healthy development of the mother and fetus, as well as an important cause of maternal mortality in current conditions. It has been suggested that 25(OH)D is an independent risk factor for hypertension in pregnancy, but its mechanism is complex and the clinical theory is unclear and needs further study. A large number of studies have now shown that 25(OH)D is associated with hypertensive disorders in pregnancy, and its deficiency may lead to a substantial increase in the probability of hypertensive disorders in pregnancy, play-ing an integral role in the development of hypertensive disorders in pregnancy.
文章引用：刘淑媚, 杨晓彦. 血清25(OH)D在妊娠期高血压疾病孕妇中的水平及与其严重程度的关系[J]. 临床医学进展, 2022, 12(8): 7745-7750. https://doi.org/10.12677/ACM.2022.1281116

参考文献

[1] Bilodeau, J.-F. (2013) Maternal and Placental Antioxidant Response to Preeclampsia: Impact on Vasoactive Eicosanoids. Placenta, 34, A5. [Google Scholar] [CrossRef] 
[2] 周辉, 谭译, 肖思科. 孕早期血清25羟维生素D水平与妊娠期糖尿病的相关性[J]. 医学临床研究, 2015, 32(10): 2043-2044.
[3] 李丽, 付强强. 中国妊娠期高血压疾病患病率的Meta分析[J]. 中国妇幼保健, 2019, 34(14): 3378-3381.
[4] Ghulmiyyah, L. and Sibai, B. (2012) Maternal Mortality from Preeclampsia/Eclampsia. Seminars in Perinatology, 36, 56-59. [Google Scholar] [CrossRef] [PubMed]
[5] Hutabarat, M., Wibowo, N., Obermayer-Pietsch, B. and Hup-pertz, B. (2018) Impact of Vitamin D and Vitamin D Receptor on the Trophoblast Survival Capacity in Preeclampsia. PLOS ONE, 13, Article ID: e0206725. [Google Scholar] [CrossRef] [PubMed]
[6] Keane, K.N., Cruzat, V.F., Calton, E.K., Hart, P.H., Soares, M.J., Newsholme, P., et al. (2017) Molecular Actions of Vitamin D in Reproductive Cell Biology. Reproduction, 153, R29-R42. [Google Scholar] [CrossRef] 
[7] 朱学创, 李利华, 尹雪艳. 维生素D和高血压发病的研究进展[J]. 中国动脉硬化杂志, 2010, 18(12): 1001-1003.
[8] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志, 2020, 55(4): 227-238.
[9] 余玉华, 钟春华, 刘华俭, 许明明. 妊娠中晚期子宫动脉血流阻力在子痫前期预测的临床研究[J]. 中国医学创新, 2016, 13(3): 145-148.
[10] 卢星星. 妊娠期高血压疾病早期诊断研究进展[J]. 母婴世界, 2020(18): 291-292.
[11] Sargent, I.L., Germain, S.J., Sacks, G.P., Kumar, S. and Redman, C.W.G. (2003) Trophoblast Deportation and the Maternal Inflammatory Response in Pre-Eclampsia. Journal of Reproductive Immunology, 59, 153-160. [Google Scholar] [CrossRef] 
[12] 吴建凤. 不同病情程度妊娠期高血压疾病患者血清整合素β1、γ干扰素诱导蛋白16水平变化及临床意义[J]. 医学理论与实践, 2022, 35(10): 1750-70.
[13] 陈伟伟, 李伟伟, 聂红艳, 庞静, 闫娅妮. 子宫动脉彩色多普勒超声联合血清指标预测妊娠高血压发病风险的研究[J]. 河北医药, 2022, 44(9): 1357-1360.
[14] 张燕, 卫玲, 刘媛媛, 刘国栋, 梁秀文, 季新梅. 妊娠期高血压患者Tgf-β1水平及其基因rs1800469 C/T位点多态性分析[J]. 中国优生与遗传杂志, 2020, 28(6): 679-681+744.
[15] 韩懿, 司徒文慈, 雷巧茹. 妊娠早期血清25羟基维生素D水平与妊娠期高血压及疾病严重程度的相关分析[J]. 广东医科大学学报, 2019, 37(3): 256-60.
[16] Achkar, M., Dodds, L., Giguère, Y., Forest, J.C., Armson, B.A., Woolcott, C., et al. (2015) Vitamin D Status in Early Pregnancy and Risk of Preeclampsia. American Journal of Obstetrics and Gynecology, 212, 511.e1-511.e7. [Google Scholar] [CrossRef] [PubMed]
[17] Santorelli, G., Whitelaw, D., Farrar, D., West, J. and Lawlor, D.A. (2019) Associations of Maternal Vitamin D, Pth and Calcium with Hypertensive Disorders of Pregnancy and Associated Adverse Perinatal Outcomes: Findings from the Born in Bradford Cohort Study. Scientific Reports, 9, Article No. 1205. [Google Scholar] [CrossRef] [PubMed]
[18] Lee, C.L., Ng, B.K., Wu, L.L., Cheah, F.C., Othman, H. and Ismail, N.A.M. (2017) Vitamin D Deficiency in Pregnancy at Term: Risk Factors and Pregnancy Outcomes. Hormone Molecular Biology and Clinical Investigation, 31, Article ID: 20170005. [Google Scholar] [CrossRef] [PubMed]
[19] 郝永秀. 孕期补充维生素C和(或)E预防妊娠期高血压疾病的效果及其安全性的Meta分析[D]: [硕士学位论文]. 太原: 山西医科大学, 2016.
[20] Personnaz, J., Piccolo, E., Branchereau, M., Filliol, A., Paccoud, R., Moreau, E., et al. (2019) Macrophage-Derived Hmgb1 Is Dispensable for Tissue Fibrogenesis. FASEB BioAdvances, 1, 227-245. [Google Scholar] [CrossRef] [PubMed]
[21] 郑莉莉. 血清Hmgb1、D25-(Oh)-D和Apn与妊娠期高血压的关系[J]. 中国计划生育学杂志, 2021, 29(10): 2170-2172.
[22] 张静, 韩雪, 孙敬霞. 维生素D与妊娠期高血压疾病的相关性研究进展[J]. 中国生育健康杂志, 2020, 31(1): 84-86.
[23] Nguyen, T.P., Yong, H.E., Chollangi, T., Borg, A.J., Brennecke, S.P. and Murthi, P. (2015) Placental Vitamin D Receptor Expression Is Decreased in Human Idiopathic Fetal Growth Restriction. Journal of Molecular Medicine, 93, 795-805. [Google Scholar] [CrossRef] [PubMed]
[24] Murthi, P., Yong, H.E., Ngyuen, T.P., Ellery, S., Singh, H., Rahman, R., et al. (2016) Role of the Placental Vitamin D Receptor in Modulating Feto-Placental Growth in Fetal Growth Restriction and Preeclampsia-Affected Pregnancies. Frontiers in Physiology, 7, Article No. 43. [Google Scholar] [CrossRef] [PubMed]
[25] Caccamo, D., Cannata, A., Ricca, S., Catalano, L.M., Montalto, A.F., Alibrandi, A., et al. (2020) Role of Vitamin-D Receptor (VDR) Single Nucleotide Polymorphisms in Gestational Hypertension Development: A Case-Control Study. PLOS ONE, 15, Article ID: e0239407. [Google Scholar] [CrossRef] [PubMed]
[26] 胡馨予, 周丹, 李吉良, 蒋再英, 彭娜, 秦艳, 等. 孕妇25羟维生素D水平与妊娠高血压疾病的相关性研究[J]. 医药前沿, 2019, 9(7): 168-170.
[27] O’Callaghan, K.M. and Kiely, M. (2018) Systematic Review of Vitamin D and Hypertensive Disorders of Pregnancy. Nutrients, 10, Article No. 294. [Google Scholar] [CrossRef] [PubMed]
[28] 亓慧敏. 血清25羟基维生素D在妊娠期高血压患者中水平及与严重程度的关系[J]. 西藏医药, 2020, 41(6): 34-36.
[29] 翟红卫, 蒋蕾. 妊娠期高血压疾病患者血清25-(Oh)D、Mpv、Hcy水平与病情程度关系[J]. 中国计划生育学杂志, 2020, 28(7): 1033-1036.
[30] Wang, W., Du, T. and Jiang, X. (2021) Correlation between 25-Hydroxyvitamin D, Sflt-1, Plgf, and Hypertension in Pregnancy. Journal of Healthcare Engineering, 2021, Article ID: 9371953. [Google Scholar] [CrossRef] [PubMed]
[31] Ross, A.C., Tay-lor, C.L., Yaktine, A.L., et al. (2012) Dietary Reference Intakes for Calcium and Vitamin D. Pediatrics, 130, Article No. e1427. [Google Scholar] [CrossRef] 
[32] World Health Organization (2012) Guideline: Vitamin D Supplementation in Pregnant Women. World Health Organization, Geneva.
[33] Palacios, C., Kostiuk, L.K. and Pe-ña-Rosas, J.P. (2016) Vitamin D Supplementation for Women during Pregnancy. Cochrane Database of Systematic Re-views, No. 1, Article No. CD008873. [Google Scholar] [CrossRef] [PubMed]
[34] Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gor-don, C.M., Hanley, D.A., Heaney, R.P., et al. (2011) Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 96, 1911-1930. [Google Scholar] [CrossRef] [PubMed]
[35] Serrano-Díaz, N.C., Gamboa-Delgad, E.M., Domínguez-Urrego, C.L., Vesga-Varela, A.L., Serrano-Gómez, S.E. and Quintero-Lesmes, D.C. (2018) Vitamin D and Risk of Preeclampsia: A Systematic Review and Meta-Analysis. Biomedica, 38, 43-53. [Google Scholar] [CrossRef] [PubMed]

为你推荐